XHKG
1349
Market cap102mUSD
Jul 09, Last price
2.37HKD
1D
-1.25%
1Q
-17.71%
Jan 2017
-63.43%
IPO
216.00%
Name
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
PFC Device Inc., along with its subsidiaries, focuses on the innovation, design, production, and distribution of power discrete semiconductors, which are sold under its proprietary PFC brand. Its market reach extends throughout China, Hong Kong, Taiwan, and other Asian territories. The company's diverse product range includes rectifiers, MOSFETs, IGBTs, bridge rectifiers, and various packaging solutions, serving critical applications in general power systems, consumer electronics, industrial machinery, and the automotive sector. Additionally, PFC Device Inc. supplies power supply units, specialized packaging for mobile phone chargers, and power management solutions for network and communication infrastructure. The company also undertakes investment activities and holds trademarks. Founded in 2016, PFC Device Inc. is headquartered in Chai Wan, Hong Kong, and operates as a subsidiary of Lotus Atlantic Limited.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||